Thank you to our speakers, sponsors, and delegates who joined us in Boston for the 2nd Retinal Imaging Biomarkers & Endpoints Summit! If you are interested in the 2025 event, please get in touch at

Enabling Faster & More Accurate Endpoints with Novel Retinal Imaging & AI Technology

Ran June 25 - 27 | Boston, MA

The Definitive Industry Forum Dedicated to Accelerating & Implementing the Potential of Retinal Imaging

As the 2nd Retinal Imaging Biomarkers & Endpoints Summit returned to Boston this summer, 80+ ophthalmic R&D scientists, imaging technology experts and algorithm engineers joined to discuss how they can harness the potential and implement novel retinal imaging tools for faster disease diagnosis and patient detection, streamlined clinical trials with accurate data readouts and non-invasive therapeutic interventions to improve patient’s quality of life.

24+ expert speakers from the likes of AbbVie, Alexion Pharmaceuticals, Astellas, Boehringer Ingelheim, Genentech, Novartis and Regeneron were present for the only industry-dedicated event focusing on streamlining imaging data analysis with the implementation of AI-based predictive measures for earlier detection and diagnosis to optimize patient stratification, selection and recruitment for trials.


World-Class Imaging Expert Speakers Included:

Past Attendees Included:

“This Retinal Imaging Biomarkers & Endpoints meeting offers both excellent networking opportunities as well as a chance to stay on top of developments in the field.”

Principal Scientist II, Novartis

2024 Partners:

Other Events in the Ophthalmology Series: